0001246360-14-004749.txt : 20141219
0001246360-14-004749.hdr.sgml : 20141219
20141219175609
ACCESSION NUMBER: 0001246360-14-004749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141217
FILED AS OF DATE: 20141219
DATE AS OF CHANGE: 20141219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sanj K
CENTRAL INDEX KEY: 0001532218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 141300898
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-12-17
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001532218
Patel Sanj K
33 HAYDEN AVE
LEXINGTON
MA
02421
true
true
false
false
President & CEO
Common Stock
2014-12-17
4
M
false
13536
1.7
A
14567
D
Common Stock
2014-12-17
4
M
false
5016
3.52
A
19583
D
Common Stock
2014-12-17
4
M
false
31448
23
A
51031
D
Common Stock
2014-12-17
4
S
false
5016
87.25
D
46015
D
Common Stock
2014-12-17
4
S
false
13536
87.55
D
32479
D
Common Stock
2014-12-17
4
S
false
4488
87.26
D
27991
D
Common Stock
2014-12-17
4
S
false
26960
90.06
D
1031
D
Stock Option (Right to Buy)
1.7
2014-12-17
4
M
false
13536
0
D
2021-05-25
Common Stock
13536
22512
D
Stock Option (Right to Buy)
3.52
2014-12-17
4
M
false
5016
0
D
2018-09-24
Common Stock
5016
0
D
Stock Option (Right to Buy)
23
2014-12-17
4
M
false
31448
0
D
2021-12-20
Common Stock
31448
136052
D
The stock option exercise and sale of shares of the Company's common stock (the "Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 3, 2014.
The Stock Option granted the reporting person an option to purchase 108,052 Shares. 25% of such Shares vested and became exercisable on 5/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
The Stock Option granted the reporting person two options on 09/24/2008. These options are combined for reporting purposes herein. The first option was to purchase 99,017 Shares. 25% of such Shares vested and became exercisable on 6/23/2009, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The second was an option to purchase 33,005 Shares. 25% of such Shares vested and became exercisable on 9/24/2010, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter.
The Stock Option granted the reporting person an option to purchase 167,500 Shares. 25% of such Shares vested and became exercisable on 12/20/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.21 to $87.27. The price reported in this row reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.17 to $87.77. The price reported in this row reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in a trade through a broker-dealer.
/s/ Sanj K. Patel
2014-12-19